$1.90
-0.04-2.06%
Last update: Oct 23, 4:04 PM
Elicio Therapeutics Inc (ELTX) Stock Price, Quote, News & History
ELTXNASDAQ
Elicio shares complete response data for ELI-002 7P in KRAS pancreatic cancer and plans combination studies after mixed Phase 2 results.
You can purchase shares of Elicio Therapeutics (NASDAQ:ELTX) through any online brokerage.
Other companies in Elicio Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Elicio Therapeutics has a consensus price target of $14.83.
The stock price for Elicio Therapeutics (NASDAQ: ELTX) is $1.9 last updated October 23, 2026 at 4:04 PM EDT.
There are no upcoming dividends for Elicio Therapeutics.
Elicio Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Elicio Therapeutics.
Elicio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The...
